StockDiagnosis

ABBV Stock Analysis — AbbVie Inc

AI-powered earnings and news diagnosis. Updated regularly.

Company Overview

Sector
HEALTHCARE
P/E Ratio
124.09
EPS
$2.05
Profit Margin
0.0579

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

No public analysis available yet for ABBV.

Get a fresh AI diagnosis of ABBV

Sign up free — 3 analyses per month included.

Analyze ABBV Now